A Randomized, Double-Blind, Placebo-Controlled, Phase 1/2 Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Multiple-Doses of AOC 1001 Administered Intravenously to Adult Myotonic Dystrophy Type 1 (DM1) Patients
Details
Age
Adult
Type of Study
Treatment
Locations
Brain Imaging Center (BIC)
CTRC Inpatient
Outpatient CTRC
University of Colorado Hospital
Principal Investigator
Dianna Quan, MD
Study ID
Protocol Number: 21-3032
More information available at ClinicalTrials.gov: NCT05027269
Categories
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers